CMMB
Chemomab Therapeutics
CMMB
CMMB
16 hedge funds and large institutions have $15.9M invested in Chemomab Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $22.7M → $15.9M (-$6.8M)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.38M | |
| 2 | +$134K | |
| 3 | +$60.6K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$52K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$13.7K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$155K | |
| 3 | -$83K | |
| 4 |
Morgan Stanley
New York
|
-$80K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$78K |